Nursing Leadership of Successful Clinical Trial Recruitment Strategies to an NCCCP Endorsed Study

2.50
Hdl Handle:
http://hdl.handle.net/10755/164803
Category:
Abstract
Type:
Presentation
Title:
Nursing Leadership of Successful Clinical Trial Recruitment Strategies to an NCCCP Endorsed Study
Author(s):
Servodidio, Camille; Neri, Diane; Ellison, Christie; Williams, Pam; Gonzalez, Maria; Bryant, Donna; Duggan, Brenda
Author Details:
Camille Servodidio, RN, MPH, CRNO, OCN ,CCRP, Director, Cancer Clinical Research Office, Hartford Hospital, Hartford, Connecticut, USA, email: cservod@harthosp.org; Diane Neri, RN, OCN; Christie Ellison, RN, BSN, OCN; Pam Williams, RN, MSN, CCRP; Maria Gonzalez, BS; Donna Bryant, MSN, OCN, ANP-C, CCRC; Brenda Duggan, RN, BSN, NCI, CBIIT
Abstract:
Administration/Leadership Development: The NCI Community Cancer Centers Program, NCCCP, is a three-year pilot project whose goal is to expand cancer research and deliver the latest most advanced cancer care to community settings where patients live. With input from the 16 participating NCCCP community hospitals, the NCCCP clinical trials working group endorsed the Wake Forest University, 07-02-03, Phase III Randomized, Double Blind Placebo Controlled Trial of North American Ginseng Extract to Prevent Respiratory Infection and Reduce Antibiotic Use in Patients with previously untreated Chronic Lymphocytic Leukemia, CLL. Because the trial had a brief enrollment period of two months, successful recruitment was imperative. The goal of this project is to identify nursing leadership interventions, which resulted in successful screening and enrollment of appropriate patients to a CLL trial with a limited enrollment time frame of two months. Nursing leadership at five NCCCP clinical sites implemented the following strategies to successfully screen and enroll patients into this trial: 1) Identify a dedicated staff member to screen patients such as a full time research nurse, CRA, pharmacy fellow or provide extra hours for existing research staff to screen study specific patients. 2) Maximize access to electronic medical records to screen and identify eligible CLL patients. 3) Submit protocol and ôDear Patientö template letter (prior to official protocol activation) to the IRB. 4) Identify a committed physician champion to promote the research trial. 378 patients were screened and 43 patients were enrolled into this study within a two-month time frame. Nursing leadership challenges for this study included limited time to build enthusiasm and promote the study, ongoing audits at time of study enrollment, and limited time to follow up on patient letters and phone calls. Patient barriers included those who did not want to travel to the clinic for repeated visits, concern of side effects of ginseng, patientsÆ perception that they were too busy to participate, cost to patient for additional visits, and those who were interested but were ineligible because of exclusion criteria.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2009
Conference Name:
34th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
San Antonio, Texas, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleNursing Leadership of Successful Clinical Trial Recruitment Strategies to an NCCCP Endorsed Studyen_GB
dc.contributor.authorServodidio, Camilleen_US
dc.contributor.authorNeri, Dianeen_US
dc.contributor.authorEllison, Christieen_US
dc.contributor.authorWilliams, Pamen_US
dc.contributor.authorGonzalez, Mariaen_US
dc.contributor.authorBryant, Donnaen_US
dc.contributor.authorDuggan, Brendaen_US
dc.author.detailsCamille Servodidio, RN, MPH, CRNO, OCN ,CCRP, Director, Cancer Clinical Research Office, Hartford Hospital, Hartford, Connecticut, USA, email: cservod@harthosp.org; Diane Neri, RN, OCN; Christie Ellison, RN, BSN, OCN; Pam Williams, RN, MSN, CCRP; Maria Gonzalez, BS; Donna Bryant, MSN, OCN, ANP-C, CCRC; Brenda Duggan, RN, BSN, NCI, CBIITen_US
dc.identifier.urihttp://hdl.handle.net/10755/164803-
dc.description.abstractAdministration/Leadership Development: The NCI Community Cancer Centers Program, NCCCP, is a three-year pilot project whose goal is to expand cancer research and deliver the latest most advanced cancer care to community settings where patients live. With input from the 16 participating NCCCP community hospitals, the NCCCP clinical trials working group endorsed the Wake Forest University, 07-02-03, Phase III Randomized, Double Blind Placebo Controlled Trial of North American Ginseng Extract to Prevent Respiratory Infection and Reduce Antibiotic Use in Patients with previously untreated Chronic Lymphocytic Leukemia, CLL. Because the trial had a brief enrollment period of two months, successful recruitment was imperative. The goal of this project is to identify nursing leadership interventions, which resulted in successful screening and enrollment of appropriate patients to a CLL trial with a limited enrollment time frame of two months. Nursing leadership at five NCCCP clinical sites implemented the following strategies to successfully screen and enroll patients into this trial: 1) Identify a dedicated staff member to screen patients such as a full time research nurse, CRA, pharmacy fellow or provide extra hours for existing research staff to screen study specific patients. 2) Maximize access to electronic medical records to screen and identify eligible CLL patients. 3) Submit protocol and ôDear Patientö template letter (prior to official protocol activation) to the IRB. 4) Identify a committed physician champion to promote the research trial. 378 patients were screened and 43 patients were enrolled into this study within a two-month time frame. Nursing leadership challenges for this study included limited time to build enthusiasm and promote the study, ongoing audits at time of study enrollment, and limited time to follow up on patient letters and phone calls. Patient barriers included those who did not want to travel to the clinic for repeated visits, concern of side effects of ginseng, patientsÆ perception that they were too busy to participate, cost to patient for additional visits, and those who were interested but were ineligible because of exclusion criteria.en_GB
dc.date.available2011-10-27T12:07:17Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:07:17Z-
dc.conference.date2009en_US
dc.conference.name34th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationSan Antonio, Texas, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.